Avantor, Inc. · NYSE (us_market)
Healthcare · Medical Instruments & Supplies · United States
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2026-01-13$12.60 RISE2026-05-18$7.60 PEAK2026-05-28$9.15 135d | -39.7% 125d | Missed | Missed | — | — | +20.4% 10d | Missed |
DROP2026-01-13$12.60 RISE2026-03-27$7.41 PEAK2026-05-28$9.15 135d | -41.2% 73d | Missed | Missed | — | — | +23.5% 62d | Missed |
DROP2025-10-21$15.60 RISE2025-12-09$10.63 PEAK2026-01-13$12.60 84d | -31.9% 49d | Missed | Missed | — | — | +18.5% 35d | Missed |
DROP2025-07-25$14.21 RISE2025-09-25$11.78 PEAK2025-10-21$15.60 88d | -17.1% 62d | Missed | Missed | — | — | +32.4% 26d | Missed |
DROP2025-04-02$16.29 RISE2025-08-06$11.18 PEAK2025-10-21$15.60 202d | -31.4% 126d | Missed | Missed | — | — | +39.5% 76d | Missed |
DROP2025-01-16$22.57 RISE2025-05-07$11.94 PEAK2025-07-25$14.21 190d | -47.1% 111d | Missed | Missed | — | — | +19.0% 79d | Missed |
DROP2024-03-22$26.07 RISE2024-07-02$20.58 PEAK2024-09-19$27.70 181d | -21.1% 102d | Missed | Missed | — | — | +34.6% 79d | Missed |
DROP2023-07-26$23.33 RISE2023-10-30$17.15 PEAK2023-12-19$23.08 146d | -26.5% 96d | Missed | Missed | — | — | +34.6% 50d | Missed |
DROP2023-03-03$25.10 RISE2023-06-28$19.51 PEAK2023-07-26$23.33 145d | -22.3% 117d | Missed | Missed | — | — | +19.6% 28d | Missed |
DROP2023-03-03$25.10 RISE2023-04-26$18.72 PEAK2023-07-21$23.00 140d | -25.4% 54d | Missed | Missed | — | — | +22.9% 86d | Missed |
DROP2022-09-12$26.04 RISE2023-01-06$20.07 PEAK2023-03-03$25.10 172d | -22.9% 116d | Missed | Missed | — | — | +25.1% 56d | Missed |
DROP2022-07-28$32.33 RISE2022-10-28$19.22 PEAK2023-01-26$23.82 182d | -40.6% 92d | Missed | Missed | — | — | +23.9% 90d | Missed |
DROP2020-02-06$19.24 RISE2020-03-18$8.27 PEAK2020-06-03$19.24 118d | -57.0% 41d | Missed | Missed | — | — | +132.6% 77d | Missed |
Avantor (AVTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Avantor (AVTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
AVTR's product breadth, digital upgrades and new pharma wins support growth, though VWR Distribution & Services remains a challenge.
AVTR's product breadth, digital upgrades and new pharma wins support growth, though VWR Distribution & Services remains a challenge.
Avantor, Inc. (NYSE:AVTR) is one of the 10 Best Single Digit Stocks to Buy Right Now. On May 13, RBC Capital initiated coverage on Avantor, Inc. (NYSE:AVTR), giving the stock a Sector Perform stock rating and setting the price target at $9. The research firm said that this rating reflects confidence in the company’s management […]
Avantor, Inc. (NYSE:AVTR) is one of the 10 Best Single Digit Stocks to Buy Right Now. On May 13, RBC Capital initiated coverage on Avantor, Inc. (NYSE:AVTR), giving the stock a Sector Perform stock rating and setting the price target at $9. The research firm said that this rating reflects confidence in the company’s management […]
US stock futures lower, Braze Inc (BRZE) shares drop 8.4% in pre-market trading after reporting mixed Q1 results. Other stocks also down.
What a brutal six months it’s been for Avantor. The stock has dropped 30.3% and now trades at $7.66, rattling many shareholders. This might have investors contemplating their next move.
What a brutal six months it’s been for Avantor. The stock has dropped 30.3% and now trades at $7.66, rattling many shareholders. This might have investors contemplating their next move.
According to the latest market analysis by Future Market Insights (FMI), the global Cell Culture Media Market is projected to grow from USD 3.7 billion in 2026 to USD 7.1 billion by 2036, expanding at a CAGR of 6.6% during the forecast period. Market growth is being driven by rising biologics production, expanding cell and gene therapy pipelines, increasing adoption of serum-free formulations, and growing demand for reproducible, GMP-grade manufacturing inputs across regulated biopharmaceutical
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Gerard (Jerry) Porreca has joined the company as Executive Vice President, Quality and Regulatory.
Broyhill Asset Management, an investment advisor, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The Broyhill Equity Composite declined 6.0% in the first quarter, net of all fees and expenses, lagging the MSCI All Country World Index, which declined 3.1%. After a strong start to the year, global […]
Broyhill Asset Management, an investment advisor, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The Broyhill Equity Composite declined 6.0% in the first quarter, net of all fees and expenses, lagging the MSCI All Country World Index, which declined 3.1%. After a strong start to the year, global […]
Longleaf Partners, managed by Southeastern Asset Management, released its first-quarter 2026 investor letter. A copy of the letter is available to download here. The Fund returned -4.46% in the quarter, compared to the S&P 500’s -4.33% and the Russell 1000 Value Index’s 2.10% return. The year began similarly to the second half of 2025, with rising […]
Longleaf Partners, managed by Southeastern Asset Management, released its first-quarter 2026 investor letter. A copy of the letter is available to download here. The Fund returned -4.46% in the quarter, compared to the S&P 500’s -4.33% and the Russell 1000 Value Index’s 2.10% return. The year began similarly to the second half of 2025, with rising […]
Avantor's (AVTR) turnaround narrative merits a constructive view, but that should be balanced agains
Avantor's (AVTR) turnaround narrative merits a constructive view, but that should be balanced agains
RBC Capital analyst Dan Leonard reinstates Avantor (NYSE:AVTR) with a Sector Perform and announces $9 price target.
Broyhill Asset Management details its Q1 2026 performance and portfolio shifts, highlighting major contributors and new positions. Read the full analysis for more details.
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| AVTR | +14.57% | +3.52% | -20.42% | -29.36% |
| XLV | +2.97% | -5.72% | -3.44% | +12.69% |
| Alpha (stock − sector) | +11.60% | +9.23% | -16.98% | -42.05% |
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| Wellington | fundamental | 24.22M | $189.92M | 0.04% | Added+3.4% | 2026-03-31 |
| StateStreet | passive | 20.72M | $162.45M | 0.01% | Added+2.5% | 2026-03-31 |
| DEShaw | quant | 13.11M | $102.79M | 0.06% | Added+110.9% | 2026-03-31 |
| FidelityFMR | fundamental | 7.61M | $59.66M | 0.00% | Trimmed-0.8% | 2026-03-31 |
| Bridgewater | macro | 128.2K | $1.01M | 0.00% | New | 2026-03-31 |
| TRowePrice | fundamental | 635.0K | $4.98K | 0.00% | Added+12.7% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-07-31upcoming | 0.19 | — | — |
| 2026-04-29 | 0.16 | 0.17 | +8.18% |
| 2026-02-11 | 0.22 | 0.22 | +1.54% |
| 2025-10-29 | 0.13 | -1.04 | -927.24% |
| 2025-08-01 | 0.25 | 0.24 | -2.87% |
| 2025-04-25 | 0.23 | 0.23 | -0.67% |
| 2025-02-07 | 0.26 | 0.27 | +4.55% |
| 2024-10-25 | 0.25 | 0.26 | +2.14% |
| 2024-07-26 | 0.23 | 0.25 | +7.68% |
| 2024-04-26 | 0.20 | 0.22 | +9.56% |
| 2024-02-14 | 0.22 | 0.25 | +12.07% |
| 2023-10-27 | 0.25 | 0.25 | -0.30% |
| 2023-07-28 | 0.29 | 0.28 | -4.41% |
| 2023-04-28 | 0.29 | 0.29 | +1.59% |
| 2023-02-03 | 0.30 | 0.32 | +5.95% |
| 2022-10-28 | 0.33 | 0.34 | +2.98% |